| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e0f0203559156922b25a041b2378158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d03dc1b42f3fd4547758c6a0980d5679
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b8484bcea92ca4db0179a2f28baf766
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f85f8f47c0a9afec17e150f07f2cbbe1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6037
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-627
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2021-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64b3aa3429ce268ed47aa7945622a913
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf41ae1e31df4e0e187f72de7e0e957a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_948b455bc6aa2724340ea0bebddacb6a |
| publicationDate |
2022-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022060424-A1 |
| titleOfInvention |
β-AMYLOID VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE |
| abstract |
The disclosure provides peptide compositions and immunotherapy compositions comprising an amyloid-beta (Αβ) peptide. The disclosure also provides methods of treating or effecting prophylaxis of Alzheimer's disease or other diseases with beta-amyloid deposition in a subject, including methods of clearing deposits, inhibiting or reducing aggregation of Αβ, blocking the uptake by neurons, and clearing amyloid in a subject having or at risk of developing Alzheimer's disease or other diseases containing amyloid-beta accumulations. The methods include administering to such patients the compositions comprising an. amyloid-beta (Αβ) peptide. |
| priorityDate |
2020-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |